• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    US Trade Representative Robert Lighthizer is pictured.
    Economy

    Leaked nominations documents show White House worried about Robert Lighthizer’s Democratic donations

    Sean Higgins -
    June 24, 2019 4:34 pm
    0
    This image provided by Amag Pharmaceuticals in June 2019 shows packaging for their drug Vyleesi. The medication OK'd Friday by the U.S. Food and Drug Administration is only the second approved to increase sexual desire in a women.
    Healthcare

    Coming soon to US bedrooms: Injectable ‘female Viagra’

    Kimberly Leonard -
    June 21, 2019 11:52 pm
    0
    In this Aug. 17, 2018 photo, family and friends who have lost loved ones to OxyContin and opioid overdoses leave pill bottles in protest outside the headquarters of Purdue Pharma, which is owned by the Sackler family, in Stamford, Conn. The Sackler family’s ties to OxyContin and the painkiller’s role in the deadly opioid crisis are bringing the Sacklers a new kind of attention and complicating their philanthropic legacy.
    Healthcare

    World Health Organization removes guidelines downplaying opioid addiction risk after criticism from US legislators

    Grayce McCormick -
    June 20, 2019 9:21 pm
    0
    Principal scientists Matt Drever, left, scrapes bacteria from an agar plate during an antibody phage experiment as principal scientist Charlie Holst watches.
    Business

    Pfizer gains new cancer drugs in $11.4B purchase of Array BioPharma

    James Langford -
    June 17, 2019 5:21 pm
    0
    FILE - In this March 13, 2019, file phtooHealth and Human Services Secretary Alex Azar testifies before a House Appropriations subcommittee on Capitol Hill in Washington. Azar says drugmakers will soon have to reveal prices of their prescription medicines in those ever-present TV ads. The Trump administration will issue final regulations on May 8 requiring drug companies to disclose list prices of medications costing more than $35 for a month’s supply. Azar tells The Associated Press if drugmakers are scared to put prices in ads that means they should lower those prices.
    News

    Drugmakers sue to block Trump rule requiring drug prices in TV advertisements

    Noah Garfinkel -
    June 14, 2019 9:56 pm
    0
    Medical marijuana and pill bottles.
    News

    Church suspends rules against marijuana investment

    Ellie Bufkin -
    June 13, 2019 8:04 pm
    0
    Florida Gov. Ron DeSantis (center) speaks at an event.
    Foreign Policy

    Florida Governor Ron DeSantis breaks with GOP and signs drug importation bill

    Cassidy Morrison -
    June 11, 2019 6:46 pm
    0
    Equality March for Unity and Pride participants march past the White House in Washington, Sunday, June 11, 2017.
    Beltway Confidential

    Trump isn’t sabotaging the fight against HIV — he’s leading it

    Brad Polumbo -
    June 7, 2019 7:04 pm
    0
    Trump team has the wrong twist on drug pricing policy
    Beltway Confidential

    Trump team has the wrong twist on drug pricing policy

    Quin Hillyer -
    June 7, 2019 5:41 pm
    0
    In this Jan. 30, 2019, file photo, Insys Therapeutics founder John Kapoor leaves federal court in Boston.
    Business

    Drug manufacturer to pay $225 million to end opioid investigations

    Zach Halaschak -
    June 6, 2019 12:46 am
    0
    1...626364...160Page 63 of 160
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.